Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

INTRODUCTION: About 30% of rheumatoid arthritis patients fail to respond adequately to TNFα-blocking therapy. There is a medical and socioeconomic need to identify molecular markers for an early prediction of responders and nonresponders. METHODS: RNA was extracted from peripheral blood mononuclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Koczan, Dirk, Drynda, Susanne, Hecker, Michael, Drynda, Andreas, Guthke, Reinhard, Kekow, Joern, Thiesen, Hans-Juergen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483439/
https://www.ncbi.nlm.nih.gov/pubmed/18454843
http://dx.doi.org/10.1186/ar2419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483439/
https://www.ncbi.nlm.nih.gov/pubmed/18454843
http://dx.doi.org/10.1186/ar2419

Ejemplares similares